Globalepolicy.org is a free to access global medical news service for the consumer, professional and researcher.
Our adviser: Drugs Infromation online
Background: A treatment algorithm and screening examination have been developed to guide patient management and prospectively determine potential for highly active individuals to succeed with nonoperative care after anterior cruciate ligament rupture.
Objective: To prospectively characterize and classify the entire population of highly active individuals over a 10-year period and provide final outcomes for individuals who elected nonoperative care.
Methods: Inclusion criteria included presentation within 7 months of the index injury and an International Knee Documentation Committee level I or II activity level before injury. Concomitant injury, unresolved impairments, and a screening examination were used as criteria to guide management and classify individuals as noncopers (poor potential) or potential copers (good potential) for nonoperative care.
Results: A total of 832 highly active patients with subacute anterior cruciate ligament tears were seen over the 10-year period; 315 had concomitant injuries, 87 had unresolved impairments, and 85 did not participate in the classification algorithm. The remaining 345 patients (216 men, 129 women) participated in the screening examination a mean of 6 weeks after the index injury. There were 199 subjects classified as noncopers and 146 as potential copers. Sixty-three of 88 potential copers successfully returned to preinjury activities without surgery, with 25 of these patients not undergoing anterior cruciate ligament reconstruction at the time of follow-up.
Conclusion: The classification algorithm is an effective tool for prospectively identifying individuals early after anterior cruciate ligament injury who want to pursue nonoperative care or must delay surgical intervention and have good potential to do so.
NAVIGATION
|
12
May |
Predicting The Risk Of Sudden Cardiac Arrest Using Novel Imaging Could Better Identify Patients Who Would Benefit From ICDsCategory: Heart Disease | Leave a Comment |
New research from the University at Buffalo suggests that cardiologists may have a new way to identify patients who are at the highest risk of sudden cardiac arrest, and the most likely to benefit from receiving an implantable cardiac defibrillator (ICD). ICDs are used to prevent sudden cardiac arrest in patients with advanced heart disease, but many patients’ devices are never triggered…
|
11
May |
Leading Medical Societies Collaborate To Offer Criteria For Rational And Timely Use Of Cardiac CatheterizationCategory: Heart Disease | Leave a Comment |
Cardiac catheterization - an invasive diagnostic procedure that allows doctors to see the vessels and arteries leading to the heart and its chambers - is performed thousands of times in the United States each year and, in some cases, can be the best method to diagnose heart problems…
|
30
Apr |
Fibers That Control Heart Rhythm Revealed By 3D X-RayCategory: Heart Disease | Leave a Comment |
Scientists at the University of Liverpool have developed a new X-ray technique to identify tissue fibres in the heart that ensure the muscle beats in a regular rhythm…
|
26
Apr |
New Technique Developed That Could Improve Heart Attack PredictionCategory: Heart Disease | Leave a Comment |
An award-winning research project, funded by the British Heart Foundation (BHF), has tested a new imaging method which could help improve how doctors predict a patient’s risk of having a heart attack (1)…
|
18
Apr |
Study Suggests Coronary Stents Not Harmful To Patients With History Of Metal AllergyCategory: Heart Disease | Leave a Comment |
Study is first to compare clinical outcomes after placing stents in those with and without a history of skin allergy to stent metal components…
|
21
Mar |
Estimating Heart Disease Risk With New Software ToolCategory: Heart Disease | Leave a Comment |
University of Granada researchers have developed a software tool that makes an accurate estimation of the risk that a person has to suffer a heart disease. In addition, this software tool allows the performance of massive risk estimations, i.e. it helps estimating the risk that a specific population group has of suffering a heart condition…
|
16
Mar |
Gene Chip May Help Prevent Heart DiseaseCategory: Heart Disease | Leave a Comment |
Worldwide, coronary heart disease (CHD) is the leading cause of death. According to a study published online in The Lancet, anti-inflammatory medications may become a new way to prevent and treat the disease. Using a gene analysis tool called the Cardiochip, the researchers examined a specific gene variant associated with inflammation and heart disease. The chip was designed by Brendan J…
|
14
Mar |
Innovative Treatment Program Helps Heart Failure Patients Avoid Or Delay TransplantCategory: Heart Disease | Leave a Comment |
Some patients with advanced heart failure caused by cardiomyopathy, the deterioration of function of the heart muscle, are getting a new lease on life thanks to an innovative treatment program at Jewish Hospital, a part of KentuckyOne Health, and the University of Louisville. Led by Emma Birks, M.D., Ph.D…
|
11
Jan |
New Generation Drug-Eluting Stents Associated With Lower Rates Of Mortality And Restenosis Than Bare Metal StentsCategory: Heart Disease | Leave a Comment |
A registry - which includes every patient in Sweden having percutaneous coronary intervention (PCI) for the treatment of acute and stable coronary artery disease - has found that PCI implantations using a new generation of drug-eluting stents is associated with lower rates of relapse (restenosis), stent thrombosis and subsequent mortality than older generation drug-eluting sten…
|
1
Jan |
TriReme Medical, Inc. Receives FDA 510(K) Clearance For Chocolate PTA Balloon CatheterCategory: Heart Disease | Leave a Comment |
TriReme Medical, Inc. (”TriReme”), a leading developer of innovative devices for the treatment of complex vascular disease, announced that it has received 510(K) clearance from the U.S. Food and Drug Administration to market its Chocolate PTA balloon catheter (”Chocolate”) for the treatment of occluded peripheral arteries…